Enhanced Tumor Homografts Following Pretreatment of Donor Mice.

Conclusion In 3 series of experiments employing 675 BALB/c, 108 C57BR/cd and 50 C57BL/6 mice, the first of double isografts of EO771 mammary carcinoma acquired an altered enhanced status comparable with that of the second of double isografts and each of the double isografts had 9 times the homotrans...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental biology and medicine (Maywood, N.J.) N.J.), 1959-04, Vol.100 (4), p.762-763
Hauptverfasser: Casey, A. E., Casey, J. G., Hathaway, C. O., Dowling, E. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Conclusion In 3 series of experiments employing 675 BALB/c, 108 C57BR/cd and 50 C57BL/6 mice, the first of double isografts of EO771 mammary carcinoma acquired an altered enhanced status comparable with that of the second of double isografts and each of the double isografts had 9 times the homotransplantability (24%) of single control isografts (2.7%). Within the conditions of the experiment neither size, nor age of the isograft was of importance. The altered enhanced status was abiding as determined by serial homotransplantability without further treatment.
ISSN:0037-9727
1535-3702
1535-3699
DOI:10.3181/00379727-100-24770